Frontiers | Chronic HCV infection promotes cytotoxicity in antigen-specific CD8+ T cells regardless of virus specificity
Frontiers | Direct-Acting Antiviral Treatment of HCV Infection Does Not Resolve the Dysfunction of Circulating CD8+ T-Cells in Advanced Liver Disease
Hepatitis C: The Story of a Long Journey through First, Second, and Third Generation NS3/4A Peptidomimetic Inhibitors. What Did We Learn? | Journal of Medicinal Chemistry
Suppression of Hepatitis C Virus Replication by Cyclosporin A Is Mediated by Blockade of Cyclophilins - ScienceDirect
HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape - ScienceDirect
Frontiers | Chronic HCV infection promotes cytotoxicity in antigen-specific CD8+ T cells regardless of virus specificity
Hepatitis C Virus Entry into Macrophages/Monocytes Mainly Depends on the Phagocytosis of Macrophages | Digestive Diseases and Sciences
Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment - eBioMedicine
Hepatitis C virus - Wikipedia
Hepatitis C Virus (HCV) and the Role of Phytochemicals in the Anti-Viral Effects of Different Medicinal Plants Against Infection | SpringerLink
Hepatitis C Virus (HCV) and the Role of Phytochemicals in the Anti-Viral Effects of Different Medicinal Plants Against Infection | SpringerLink
CRISPR-Cas13a mediated targeting of hepatitis C virus internal-ribosomal entry site (IRES) as an effective antiviral strategy - ScienceDirect
Hepatitis C virus - Wikipedia
Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions - ScienceDirect
HCV virology and diagnosis - ScienceDirect
Frontiers | The burden of hepatitis C virus in the world, China, India, and the United States from 1990 to 2019
Hepatitis C virus - Wikipedia
Virology and cell biology of the hepatitis C virus life cycle – An update - ScienceDirect
2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee | Circulation: Cardiovascular Interventions
Apolipoprotein E and viral infection: Risks and Mechanisms: Molecular Therapy - Nucleic Acids
Hepatitis C virus core protein activates proteasomal activator 28 gamma to downregulate p16 levels via ubiquitin-independent proteasomal degradation - ScienceDirect
HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape - ScienceDirect
